---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "i0b4N7NxGj9d2pp4PsJD1tC3bxLlBcZvneA/C0+kij7Bb3UeYrJZDYaqyD1Ww7NCD7s+eZV9vK9CwIqJdbYBlBefwmQ/1dejDbXdshow1iY9ZVt30/0+jCRwVXrwB7p0+7h3A/6y1n+GmMAnh0kRW7jvCGROx0N/9w88NWEk+gJlCEjXaj8Wse9BAD6X6E8/QitZZc8+LZfW5/BWhDe2AVCER5USkFDnxYdPOrvsHRY2wyrK8LkHfHDTFwXJrd2djYwfYLyl4c8K3jwR2hSXGY/cfaND+xNe9mNsJKWGtPgYT7Pf4aFkANC0KejHZAub;RT841tEHLu687PF4JuNWnA=="
---

